Expert Columns by Sheela Ranganathan

post by Sheela Ranganathan

Opinion & Analysis

November 20, 2024

Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription Drugs

Opinion & Analysis

May 8, 2024

Threats to EMTALA: Unpacking the Oral Arguments in Idaho v. United States

Opinion & Analysis

March 7, 2024

No Surprises Act Litigation: Where We Are and What Comes Next

Opinion & Analysis

February 1, 2024

Unpacking Recent Antitrust Challenges to Private Equity in Health Care

Opinion & Analysis

November 20, 2023

Latest Development in Legal Challenges to Arbitration Process Under No Surprises Act

---